|
|
||||||||
Fujisaki Institute, Hayashibara Biochemical Laboratories, Okayama, Japan
We investigated the effects of IL-18 on the development of
CD8+ effector T cells in DBA/2
anti-BDF1 whole spleen cell MLC and compared the
results with those of IL-12. Addition of IL-18 to the MLC resulted in a
twofold increase in CD8/CD4 ratios compared with the control cultures
when cells were expanded in IL-2-containing medium following MLC.
Purified CD8+ T cells recovered from the IL-18-stimulated
MLC produced 20- to 30-fold more IFN-
after secondary stimulation
with C57BL/6 spleen cells or anti-CD3 mAb, and exhibited strong
allospecific CTL activity. Neither IL-18 nor IL-18-supplemented culture
supernatants from DBA/2 anti-BDF1 MLC induced type I
CD8+ effector T cells when purified CD8+ T
cells were used as responder cells in primary MLC. Furthermore,
CD4+ T cell depletion from the responder cells abrogated
the IL-18-induced increase in secondary IFN-
production by
CD8+ T cells, suggesting that IL-18-induced type I effector
CD8+ T cell development was CD4+ T cell
dependent. In marked contrast, adding IL-12 to primary MLC decreased
CD8/CD4 ratios by 50% and suppressed secondary IFN-
production and
CTL activity by CD8+ T cells regardless of concentration,
whereas Th1 development was promoted by IL-12. Moreover, both IL-12 and
IL-18 efficiently induced type I CD8+ effector T cells in
C57BL/6 anti-BDF1 MLC. These findings show that IL-18
plays an important role in the generation of type I CD8+
effector T cells, and further suggest that functional maturation of
CD8+ T cells is differentially regulated by IL-18 and
IL-12.
This article has been cited by other articles:
![]() |
S. Nandakumar, S. N. Woolard, D. Yuan, B. T. Rouse, and U. Kumaraguru Natural Killer Cells as Novel Helpers in Anti-Herpes Simplex Virus Immune Response J. Virol., November 1, 2008; 82(21): 10820 - 10831. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, S.-i. Kashiwamura, H. Ueda, A. Sekiyama, and H. Okamura Protection of CD8+ T cells from activation-induced cell death by IL-18 J. Leukoc. Biol., July 1, 2007; 82(1): 142 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Yamanaka, R. Clark, R. Dowgiert, D. Hurwitz, M. Shibata, B. E. Rich, K. Hirahara, D. A. Jones, S. Eapen, H. Mizutani, et al. Expression of Interleukin-18 and Caspase-1 in Cutaneous T-Cell Lymphoma Clin. Cancer Res., January 15, 2006; 12(2): 376 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-K. Min, Y. Maeda, K. Lowler, C. Liu, S. Clouthier, D. Lofthus, E. Weisiger, J. L. M. Ferrara, and P. Reddy Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation Blood, November 15, 2004; 104(10): 3393 - 3399. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vankayalapati, P. Klucar, B. Wizel, S. E. Weis, B. Samten, H. Safi, H. Shams, and P. F. Barnes NK Cells Regulate CD8+ T Cell Effector Function in Response to an Intracellular Pathogen J. Immunol., January 1, 2004; 172(1): 130 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Baxevanis, A. D. Gritzapis, and M. Papamichail In Vivo Antitumor Activity of NKT Cells Activated by the Combination of IL-12 and IL-18 J. Immunol., September 15, 2003; 171(6): 2953 - 2959. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gherardi, J. C. Ramirez, and M. Esteban IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system J. Gen. Virol., August 1, 2003; 84(8): 1961 - 1972. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wang, C. Feliciani, B. G. Howell, I. Freed, Q. Cai, H. Watanabe, and D. N. Sauder Contribution of Langerhans Cell-Derived IL-18 to Contact Hypersensitivity J. Immunol., April 1, 2002; 168(7): 3303 - 3308. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Reddy, T. Teshima, M. Kukuruga, R. Ordemann, C. Liu, K. Lowler, and J. L.M. Ferrara Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis J. Exp. Med., November 12, 2001; 194(10): 1433 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Neighbors, X. Xu, F. J. Barrat, S. R. Ruuls, T. Churakova, R. Debets, J. F. Bazan, R. A. Kastelein, J. S. Abrams, and A. O'Garra A Critical Role for Interleukin 18 in Primary and Memory Effector Responses to Listeria monocytogenes That Extends Beyond Its Effects on Interferon {gamma} Production J. Exp. Med., August 6, 2001; 194(3): 343 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Itoi, Y. Fujimori, H. Tsutsui, K. Matsui, S. Futatsugi, H. Okamura, H. Hara, T. Hada, E. Kakishita, and K. Nakanishi Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease Blood, July 1, 2001; 98(1): 235 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vankayalapati, B. Wizel, D. L. Lakey, Y. Zhang, K. A. Coffee, D. E. Griffith, and P. F. Barnes T Cells Enhance Production of IL-18 by Monocytes in Response to an Intracellular Pathogen J. Immunol., June 1, 2001; 166(11): 6749 - 6753. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Horwood, J. Elliott, T. J. Martin, and M. T. Gillespie IL-12 Alone and in Synergy with IL-18 Inhibits Osteoclast Formation In Vitro J. Immunol., April 15, 2001; 166(8): 4915 - 4921. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Dittmer, K. E. Peterson, R. Messer, I. M. Stromnes, B. Race, and K. J. Hasenkrug Role of Interleukin-4 (IL-4), IL-12, and Gamma Interferon in Primary and Vaccine-Primed Immune Responses to Friend Retrovirus Infection J. Virol., January 15, 2001; 75(2): 654 - 660. [Abstract] [Full Text] |
||||
![]() |
H. T. Maecker, G. Hansen, D. M. Walter, R. H. DeKruyff, S. Levy, and D. T. Umetsu Vaccination with Allergen-IL-18 Fusion DNA Protects Against, and Reverses Established, Airway Hyperreactivity in a Murine Asthma Model J. Immunol., January 15, 2001; 166(2): 959 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tanaka, W. Hashimoto, H. Okamura, P. D. Robbins, M. T. Lotze, and H. Tahara Rapid Generation of Potent and Tumor-specific Cytotoxic T Lymphocytes by Interleukin 18 Using Dendritic Cells and Natural Killer Cells Cancer Res., September 1, 2000; 60(17): 4838 - 4844. [Abstract] [Full Text] |
||||
![]() |
P. Brossart, A. Zobywalski, F. Grünebach, L. Behnke, G. Stuhler, V. L. Reichardt, L. Kanz, and W. Brugger Tumor Necrosis Factor {{alpha}} and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells Cancer Res., August 1, 2000; 60(16): 4485 - 4492. [Abstract] [Full Text] |
||||
![]() |
I. Okamoto, K. Kohno, T. Tanimoto, K. Iwaki, T. Ishihara, S. Akamatsu, H. Ikegami, and M. Kurimoto IL-18 Prevents the Development of Chronic Graft-Versus-Host Disease in Mice J. Immunol., June 1, 2000; 164(11): 6067 - 6074. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Campbell, S. L. Kunkel, R. M. Strieter, and N. W. Lukacs Differential Roles of IL-18 in Allergic Airway Disease: Induction of Eotaxin by Resident Cell Populations Exacerbates Eosinophil Accumulation J. Immunol., January 15, 2000; 164(2): 1096 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hansen, V. P. Yeung, G. Berry, D. T. Umetsu, and R. H. DeKruyff Vaccination with Heat-Killed Listeria as Adjuvant Reverses Established Allergen-Induced Airway Hyperreactivity and Inflammation: Role of CD8+ T Cells and IL-18 J. Immunol., January 1, 2000; 164(1): 223 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Schober, C. T. Kuo, K. S. Schluns, L. Lefrancois, J. M. Leiden, and S. C. Jameson Expression of the Transcription Factor Lung Kruppel-Like Factor Is Regulated by Cytokines and Correlates with Survival of Memory T Cells In Vitro and In Vivo J. Immunol., October 1, 1999; 163(7): 3662 - 3667. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |